- +1 858 909 0079
- +1 858 909 0057
- [email protected]
- +1 858 909 0079
- [email protected]
Cat# | Products (Recombinant protein) | Swiss Prot# | Size | Price (US$) | Order |
PL0216 | Recombinant protein-Encephalitozoon cuniculi Proliferating cell nuclear antigen (a.a.21 to 267) | Q8SRV9 | 100 µg | 1195 | |
PL0217 | Recombinant protein-Encephalitozoon cuniculi-Microsporidian parasite-Spore wall protein 1 (a.a.25 to 450) | Q9XZV1 | 100 µg | 1195 | |
RPL0216 | cDNA-Encephalitozoon cuniculi Proliferating cell nuclear antigen (a.a.21 to 267) | Q8SRV9 | 2 µg | 1476 | |
RPL0217 | cDNA-Encephalitozoon cuniculi-Microsporidian parasite-Spore wall protein 1 (a.a.25 to 450) | Q9XZV1 | 2 µg | 2550 |
Encephalitozoon cuniculi cDNA and recombinant antigen
Encephalitozoon cuniculi is a microsporidian parasite that can cause various diseases in mammals, including rabbits and humans. Proliferating cell nuclear antigen (PCNA) is a protein that plays a crucial role in DNA replication and repair. Spore wall protein 1 (SWP1) is one of the major structural components of the spore wall of Encephalitozoon cuniculi. In this article, we will discuss the significance of meta title and description for Encephalitozoon cuniculi, Proliferating cell nuclear antigen, Microsporidian parasite-Spore wall protein 1, and their association with the microsporidian parasite.
Proliferating cell nuclear antigen (PCNA) is a protein that plays a crucial role in DNA replication and repair. It acts as a sliding clamp that binds to DNA polymerase and enhances its processivity. PCNA is essential for the fidelity of DNA replication and repair and is conserved in all eukaryotes.
Spore Wall Protein 1 (SWP1) and the Structure of Encephalitozoon Cuniculi Spores
The use of recombinant proteins/cDNA in academic research and therapeutic applications has skyrocketed. However, in heterologous expression systems, successful recombinant protein expression is dependent on a variety of factors, including codon preference, RNA secondary structure, and GC content. When compared to pre-optimization, more and more experimental results demonstrated that the expression level was dramatically increased, ranging from two to hundred times depending on the gene. Bioclone has created a proprietary technology platform that has resulted in the creation of over 6,000 artificially synthesized codon-optimized cDNA clones (cloned in E. coli expression Vector), which are ready for production of the recombinant proteins.
Get the Latest News and Updates by Email
6393 Nancy Ridge Dr. Suite A
San Diego, CA 92121 USA
Fax: +1-858-909-0057
Get the Latest News and Updates by Email
© 2023 Bioclone Inc. All Rights Reserved.
Magnetic Beads Make Things Simple